Vivozon Pharmaceutical Co., Ltd. (KOSDAQ: 082800)

Market Cap	398.99B
Revenue (ttm)	87.28B
Net Income (ttm)	-2.71B
Shares Out	49.38M
EPS (ttm)	-57.36
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	775,104
Average Volume	1,665,892
Open	7,980.00
Previous Close	8,080.00
Day's Range	7,750.00 - 8,230.00
52-Week Range	2,715.00 - 13,600.00
Beta	-0.15
RSI	55.21
Earnings Date	Mar 21, 2025

About Vivozon Pharmaceutical

Vivozon Pharmaceutical Co., Ltd. researches, develops, produces, and sells LED products primarily in South Korea. The company offers LED packages for interior, general, indoor, decorative, and automotive lighting, as well as display applications. It also provides LED set linear lamps, including panel lamps, down lights, and flood lights for residential, commercial, and industrial structures, as well as lights for parking lots. In addition, the company operates Echo House, a lighting show room that sells LED florescent lamps, LED flat lamps, LED...

• Industry: Electronic Components, not elsewhere classified
• Founded: 2002
• Employees: 328
• Stock Exchange: KOSDAQ
• Ticker Symbol: 082800

Financial Performance

In 2023, Vivozon Pharmaceutical's revenue was 71.32 billion, an increase of 38.31% compared to the previous year's 51.56 billion. Losses were -3.36 billion, -91.59% less than in 2022.